Activity of ABT-737, an, inhibitor of BCL-2 family proteins, in imatmib- or dasatinib-resistant CML cells: Involvement of BCL2 family proteins for drug resistance

被引：0
|
作者：
Tauchi, T
Nunoda, K
Takaku, T
Sumi, M
Akahane, D
Sashida, G
Ohyashiki, JH
Ohyashiki, K
机构：
[1] Tokyo Med Univ, Dept Internal Med 1, Shinjuku Ku, Tokyo, Japan
[2] Tokyo Med Univ, Intractable Dis Res Ctr, Shinjuku Ku, Tokyo, Japan
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3364
引用
收藏
页码：940A / 940A
页数：1
相关论文
共 50 条
  • [1] ABT-737, an inhibitor of Bcl-2 family proteins, is a potent inducer of apoptosis in multiple myeloma cells
    M P Kline
    S V Rajkumar
    M M Timm
    T K Kimlinger
    J L Haug
    J A Lust
    P R Greipp
    S Kumar
    Leukemia, 2007, 21 : 1549 - 1560
  • [2] ABT-737, an inhibitor of Bcl-2 family proteins, is a potent inducer of apoptosis in multiple myeloma cells
    Kline, M. P.
    Rajkumar, S. V.
    Timm, M. M.
    Kimlinger, T. K.
    Haug, J. L.
    Lust, J. A.
    Greipp, P. R.
    Kumar, S.
    LEUKEMIA, 2007, 21 (07) : 1549 - 1560
  • [3] MEDI 18-Discovery of ABT-737, an inhibitor of Bcl-2 family proteins that promotes apoptosis
    Wendt, Michael D.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232
  • [4] ABT-737, an inhibitor of Bcl-2/Bcl-XL proteins, is cytotoxic in multiple myeloma cells.
    Kline, M
    Kimlinger, T
    Timm, M
    Haug, J
    Lust, JA
    Rajkumar, SV
    Kumar, S
    BLOOD, 2005, 106 (11) : 455A - 455A
  • [5] Targeting Bcl-2 family proteins in adult T-cell leukemia/lymphoma: In vitro and in vivo effects of the novel Bcl-2 family inhibitor ABT-737
    Ishitsuka, Kenji
    Kunami, Naoko
    Katsuya, Hiroo
    Nogami, Rumiko
    Ishikawa, Chie
    Yotsumoto, Fusanori
    Tanji, Hiroe
    Mori, Naoki
    Takeshita, Morishige
    Miyamoto, Shingo
    Tamura, Kazuo
    CANCER LETTERS, 2012, 317 (02) : 218 - 225
  • [6] The Bcl-2/Bcl-XL family inhibitor ABT-737 sensitizes ovarian cancer cells to carboplatin
    Witham, James
    Valenti, Melanie R.
    De-Haven-Brandon, Alexis K.
    Vidot, Susanne
    Eccles, Suzanne A.
    Kaye, Stan B.
    Richardson, Alan
    CLINICAL CANCER RESEARCH, 2007, 13 (23) : 7191 - 7198
  • [7] Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins
    Tagscherer, K. E.
    Fassl, A.
    Campos, B.
    Farhadi, M.
    Kraemer, A.
    Boeck, B. C.
    Macher-Goeppinger, S.
    Radlwimmer, B.
    Wiestler, O. D.
    Herold-Mende, C.
    Roth, W.
    ONCOGENE, 2008, 27 (52) : 6646 - 6656
  • [8] Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins
    K E Tagscherer
    A Fassl
    B Campos
    M Farhadi
    A Kraemer
    B C Böck
    S Macher-Goeppinger
    B Radlwimmer
    O D Wiestler
    C Herold-Mende
    W Roth
    Oncogene, 2008, 27 : 6646 - 6656
  • [9] Synergistic Activity of Fenretinide and the Bcl-2 Family Protein Inhibitor ABT-737 against Human Neuroblastoma
    Fang, Hua
    Harned, Theresa M.
    Kalous, Ondrej
    Maldonado, Vanessa
    DeClerck, Yves A.
    Reynolds, C. Patrick
    CLINICAL CANCER RESEARCH, 2011, 17 (22) : 7093 - 7104
  • [10] Targeting the Bcl-2 family of proteins in Hodgkin lymphoma: in vitro cytotoxicity, target modulation and drug combination studies of the Bcl-2 homology 3 mimetic ABT-737
    Jayanthan, Aarthi
    Howard, Scott C.
    Trippett, Tanya
    Horton, Terzah
    Whitlock, James A.
    Daisley, Lara
    Lewis, Victor
    Narendran, Aru
    LEUKEMIA & LYMPHOMA, 2009, 50 (07) : 1174 - 1182
12345